Related Experiment Videos
Secular changes in anthropometric data in cystic fibrosis patients
E M Laursen1, C Koch, J H Petersen
1Department of Growth and Reproduction GR, State University Hospital, Rigshospitalet, Copenhagen, Denmark.
Acta Paediatrica (Oslo, Norway : 1992)
|April 2, 1999
Summary
Secular changes in cystic fibrosis (CF) patients show increased BMI and altered peak height velocity, suggesting improved treatments. These changes helped overcome selection bias in milder disease forms.
Area of Science:
- Pediatric Endocrinology
- Growth and Development
- Cystic Fibrosis Research
Background:
- Anthropometric data in cystic fibrosis (CF) patients are crucial for monitoring growth and clinical status.
- Understanding secular trends in these metrics can reveal impacts of evolving medical interventions.
- Previous studies have indicated improvements in CF patient outcomes over time.
Purpose of the Study:
- To investigate secular changes in anthropometric data, including height, BMI, and pubertal growth velocity, in CF patients from the 1960s to the 1990s.
- To assess if improvements in treatment have led to measurable changes in growth patterns over calendar time.
- To evaluate the influence of disease severity and survival bias on observed anthropometric trends.
Main Methods:
- Growth curves were developed for 270 CF patients using historical height and weight data.
- Analysis focused on secular changes in height, body mass index (BMI), peak height velocity (PHV) magnitude, and age at PHV.
- Statistical analysis compared data across different decades (1960s-1990s) and age groups.
Main Results:
- Significant increases in BMI were observed in 10- and 15-year-old boys and girls, and 5-year-old girls.
- The magnitude of pubertal peak height velocity (PHV) changed significantly over time, while the age at PHV remained constant.
- Height changes over time were not significant across most age groups, potentially due to selection bias favoring milder disease forms.
Conclusions:
- Increased BMI and altered PHV magnitude in CF patients suggest positive impacts of improved treatments on pubertal development and clinical status.
- These observed changes were substantial enough to mitigate the effects of selection bias related to survival of milder disease forms.
- The findings highlight the importance of long-term anthropometric monitoring in CF to assess treatment efficacy and population health trends.